Current Perspective on the Pathogenesis of Small Intestinal Neuroendocrine Tumors: Progress in Biomarkers and

Ying-Xuan Chen1, Jing-Yuan Fang1

  • 1Division of Gastroenterology and Hepatology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai Institute of Digestive Disease, Shanghai, China.

Gastrointestinal Tumors
|December 18, 2015
PubMed
Abstract

Insights

Small intestinal neuroendocrine tumors (SI-NETs) present with vague symptoms, leading to delayed diagnosis. Understanding their molecular changes is key for earlier detection and improved treatment of these rare gastrointestinal cancers.

Area of Science:

  • Gastroenterology
  • Oncology
  • Molecular Biology

Background:

  • Neuroendocrine tumors of the gastrointestinal tract exhibit diverse histopathology and clinical features.
  • Small intestinal neuroendocrine tumors (SI-NETs) are rare gastrointestinal malignancies often diagnosed late due to nonspecific symptoms.
  • Rising incidence of SI-NETs necessitates earlier diagnosis and effective therapies, driven by molecular insights.

Purpose of the Study:

  • To review the biomolecular alterations driving small intestinal neuroendocrine tumor (SI-NET) pathogenesis.
  • To identify potential biomarkers for the diagnostic and prognostic assessment of SI-NETs.

Main Methods:

  • Literature review of studies on SI-NET pathogenesis.
  • Analysis of molecular mechanisms and biomarker research in SI-NETs.

Main Results:

  • Specific biomolecular changes contribute to SI-NET development.
  • Identified potential biomarkers for improved diagnostic and prognostic evaluation.

Conclusions:

  • Understanding SI-NET molecular pathogenesis is crucial for clinical advancement.
  • Biomarkers hold promise for enhancing the diagnosis and prognosis of SI-NETs.

Related Concept Videos